Trade ATNM stock anytime, 24x5 in Singapore
Regulated by
Monetary Authority of Singapore (MAS)
Trusted by
400,000+ users
Actinium Pharmaceuticals, Inc (ATNM) is trading at US$1.22, up 2.52% today as of Sep 18, 16:00 EDT. The company has a market capitalisation of US$34.51M. Over the past 52 weeks, ATNM has traded between US$0.74 and US$1.74. On Syfe you can trade ATNM with $0 commission and add it to your watchlist.
| Previous close | US$1.19 |
|---|---|
| Market cap | US$34.51M |
| 52-week range | US$0.74 – US$1.74 |
| Volume | 146.17K |
| Exchange | US |
Add to Watchlist
Set Price Alert
Actinium Pharmaceuticals, Inc
Actinium Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company, which engages in the research, discovery, and clinical development of targeted radiotherapies. It also develops and markets medicines for relapsed and refractory cancer patients. The company was founded in 2000 and is headquartered in New York, NY.
Year: 2007
Actinium Pharmaceuticals, Inc (ATNM) stock is trading at US$1.22, +2.52% from the previous close of US$1.19.
The market cap for Actinium Pharmaceuticals, Inc (ATNM) stock is approximately US$34.51M.
The 52-week high for Actinium Pharmaceuticals, Inc (ATNM) stock is US$1.74.
The 52-week low for Actinium Pharmaceuticals, Inc (ATNM) stock is US$0.74.
Actinium Pharmaceuticals, Inc (ATNM) does not currently pay a dividend.
Stay on top of ATNM
Price moves, news and earnings — straight to your inbox.
Est. order value
US$0.00
Snapshot
Popular Stocks in Singapore
